Skip to main content
Log in

Ornithine transcarbamylase deficiency in pregnancy

  • Case Report
  • Published:
Journal of Inherited Metabolic Disease

An Erratum to this article was published on 01 September 2005

Summary

Women heterozygous for mutations at the ornithine transcarbamylase (OTC) locus may be at risk for hyperammonaemia and its untoward effects including coma and death in the postpartum period. We present the case of a pregnant woman heterozygous for OTC deficiency (McKusick 311250) whose past medical history was significant for two prior pregnancies complicated by postpartum hyperammonaemic coma. In the index pregnancy, increased levels of serum ammonium were noted during labour. Postpartum hyperammonaemia was averted by administration of oral sodium benzoate. Our experience demonstrates that in women at risk, perilous hyperammonaemia can be prevented through appropriate medical management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. R. Cordero.

Additional information

An erratum to this article is availale at http://dx.doi.org/10.1007/s10545-005-0001-5.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cordero, D.R., Baker, J., Dorinzi, D. et al. Ornithine transcarbamylase deficiency in pregnancy. J Inherit Metab Dis 28, 237–240 (2005). https://doi.org/10.1007/s10545-005-5514-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10545-005-5514-4

Keywords

Navigation